The SCANHEALTH project is making steady progress.
Thanks to the invaluable collaboration of our patients, we have achieved 10% of our initial two-year target (3,000 patients) in just two months.
Start of sampling for the SCANHEALTH project
We have started sampling liquid biopsy donors at the Hospital Centro Médico de Asturias. This is part of the 5-year prospective study within the SCANHEALTH project, which is developing a multi-cancer screening method in a single analysis. The goal is to recruit 3000 donors in 3 years. SCANHEALTH is funded by the AEI (CPP 2024).
Amber participated in the 10th MOIG meeting
Amber Health Solutions (Amber HS) actively participated in the 10th edition of the Madrid Open Innovation Group (MOIG), a key event organized by Enagás on November 28, 2025, which brought together universities, large companies, and startups from the innovative ecosystem of Madrid. This meeting promoted open collaboration in R, facilitating the exchange of challenges, ideas, […]
SCANHEALTH at the Week against Cancer in Asturias 2025
Amber, present at the Week Against Cancer organized by the Association Against Cancer at HUCA. Amber was present this November 5 at the conference organized by the Association Against Cancer at the Central University Hospital of Asturias (HUCA). A meeting that brought together professionals from the healthcare sector to share the latest advances in diagnosis […]
Project Funding Approved
On 30 July 2025, following the provisional resolution for the “2024 Public-Private Partnership” call, our project, “Optimization and Validation of SCANHEALTH: a Cost-Effective Infrared Spectroscopy Tool with AI Integration for Multi-Cancer Early Detection in Liquid Biopsies,” has been awarded a grant of €1,387,994.85. The SCANHEALTH consortium is comprised of the following partners: Project funded by: